Overview

Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive Disorder

Status:
Completed

Trial end date:
2015-07-27

Target enrollment:

Participant gender:

Summary

The objective of this study is to evaluate the long-term safety and tolerability of cariprazine as an adjunctive treatment to antidepressant therapy (ADT) in patients with Major Depressive Disorder (MDD).

Phase:

Phase 3

Details

Lead Sponsor:

Forest Laboratories

Collaborator:

Gedeon Richter Ltd.

Treatments:

Antidepressive Agents
Cariprazine